Modified cancer drug effective against multi-resistant bacteria

Antibiotic-resistant bacteria are increasingly the source of deadly infections. Scientists have now modified an approved cancer drug to develop an active agent against multidrug-resistant pathogens.

from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2019/12/191217105214.htm